Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China · Delayed Price · Currency is CNY 2.930
-0.040 (-1.35%)
Nov 13, 2026, 3:04 PM CST
SHE:002390 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 5,015 | 5,620 | 6,032 | 6,461 | 6,350 | 6,472 |
Revenue Growth | -12.52% | -6.84% | -6.63% | 1.75% | -1.88% | 10.71% |
Gross Profit Gross Profit Growth | 863.96 | 980.16 | 1,032 | 1,221 | 1,217 | 1,352 |
Operating Income Operating Income Growth | 311.6 | 300.62 | 282.84 | 391.05 | 332.82 | 528.56 |
Net Income Net Income Growth | 138.38 | 120.29 | 101.38 | 287.23 | 224.37 | 272.87 |
Earnings Per Share EPS Growth | 0.07 | 0.06 | 0.05 | 0.15 | 0.12 | 0.15 |
EPS Growth | 79.42% | 18.95% | -64.47% | 25.00% | -20.00% | 36.36% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Distribution Pharmaceutical Distribution Growth | 4,214 | 4,746 | 5,275 | 5,280 | 5,362 |
Medical Services Medical Services Growth | 1,575 | 1,636 | 1,788 | 1,860 | 2,071 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 1,010 | 938.69 | 843.52 | 790.26 | 704.12 |
Other Industries Other Industries Growth | 2 | 2.09 | 2.3 | 8.61 | 14.29 |
Consolidated Offset Consolidated Offset Growth | -1,182 | -1,290 | -1,447 | -1,589 | -1,680 |
Total Total Growth | 5,620 | 6,032 | 6,461 | 6,350 | 6,472 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,484 | 1,114 | 1,016 | 805.98 | 899.18 | 624.65 |
Total Debt Total Debt Growth | 378.23 | 436.85 | 787.55 | 835.38 | 1,393 | 1,415 |
Net Cash (Debt) Net Cash Growth | 1,106 | 677.04 | 227.97 | -29.4 | -493.42 | -790.6 |
Net Cash Growth | 152.85% | 196.99% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.58 | 0.36 | 0.12 | -0.02 | -0.26 | -0.43 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 907.47 | 732.53 | 634.97 | 790.62 | 590.8 | 457.97 |
Capital Expenditures CapEx Growth | -45.01 | -85.42 | -124.87 | -135.78 | -158.78 | -253.76 |
Free Cash Flow Free Cash Flow Growth | 862.46 | 647.11 | 510.1 | 654.84 | 432.02 | 204.21 |
Free Cash Flow Growth | 50.89% | 26.86% | -22.10% | 51.58% | 111.56% | -66.19% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 17.23% | 17.44% | 17.11% | 18.90% | 19.16% | 20.90% |
Operating Margin | 6.21% | 5.35% | 4.69% | 6.05% | 5.24% | 8.17% |
Pretax Margin | 5.60% | 4.09% | 3.08% | 6.13% | 4.94% | 6.51% |
Profit Margin | 2.76% | 2.14% | 1.68% | 4.45% | 3.53% | 4.22% |
FCF Margin | 17.20% | 11.52% | 8.46% | 10.13% | 6.80% | 3.16% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.090 | 0.090 | 0.060 | 0.060 | 0.060 | 0.060 |
Dividend Per Share Growth | 50.00% | 50.00% | 0% | 0% | 0% | - |
Dividend Yield | 3.07% | 2.79% | 1.32% | 1.34% | 1.28% | 0.81% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 40.15 | 50.77 | 85.11 | 29.80 | 40.72 | 52.86 |
Forward PE | - | 26.33 | 26.33 | 26.33 | 24.74 | 46.38 |
P/FCF Ratio | 6.44 | 9.44 | 16.92 | 13.07 | 21.15 | 70.63 |
PS Ratio | 1.11 | 1.09 | 1.43 | 1.33 | 1.44 | 2.23 |